{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:28:47Z","timestamp":1762874927278},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.diagmicrobio.2005.03.004","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T15:37:19Z","timestamp":1117208239000},"page":"307-310","source":"Crossref","is-referenced-by-count":55,"title":["Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens"],"prefix":"10.1016","volume":"53","author":[{"given":"Jennifer M.","family":"Streit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib1","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1128\/JCM.41.6.2795-2796.2003","article-title":"Initial quality control evaluations for susceptibility testing of dalbavancin (BI397), an investigational glycopeptide with potent Gram-positive activity","volume":"41","author":"Anderegg","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jac\/44.2.179","article-title":"In vitro and in vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic","volume":"44","author":"Candiani","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMoa025025","article-title":"Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene","volume":"348","author":"Chang","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib4","series-title":"Performance standards for antimicrobial susceptibility testing, 15th informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/JCM.33.1.24-27.1995","article-title":"Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR","volume":"33","author":"Dutka-Malen","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1469-0691.2004.01051.x","article-title":"Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centers","volume":"11","author":"Gales","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1179\/joc.2001.13.3.244","article-title":"In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent","volume":"13","author":"Jones","year":"2001","journal-title":"J. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2003.07.008","article-title":"Validation of commercial dry-form broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide","volume":"23","author":"Jones","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/AAC.48.3.1061-1064.2004","article-title":"Activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to Staphylococcus aureus with or without reduced susceptibility to vancomycin and teicoplanin","volume":"48","author":"Lefort","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AAC.48.3.940-945.2004","article-title":"Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers","volume":"48","author":"Leighton","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib11","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/423841","article-title":"Antimicrobial resistance to linezolid","volume":"39","author":"Meka","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib12","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/427283","article-title":"Efficacy and safety of weekly dalbavancin in the treatment of catheter-related bloodstream infections","volume":"40","author":"Raad","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib14","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/379015","article-title":"Once-weekly dalbavancin versus standard of care antimicrobial regimens for treatment of skin and soft tissue infections","volume":"37","author":"Seltzer","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.03.004_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diagmicrobio.2003.09.004","article-title":"Worldwide assessment of dalbavancin activity and spectrum against over 6000 clinical isolates","volume":"48","author":"Streit","year":"2004","journal-title":"Diagn. Microbiol. Infect. Dis."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T12:33:10Z","timestamp":1586262790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889305000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0732889305000660"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2005.03.004","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}